Tier 2 · Liquid 3000
Roivant Sciences Ltd.
ROIV · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.
Price
$34.37
+0.00%
Coverage
Tier 2
Tier 2 · Liquid 3000
SEC CIK
0001635088
Liquidity rank
#1049
Observed dollar volume
SEC XBRL facts
| Field | Value | Period end | Filing |
|---|---|---|---|
| Annual revenue | $8.26M | 2026-03-31 | 0001635088-26-000061 |
| Annual diluted EPS | -0.54 | 2026-03-31 | 0001635088-26-000061 |
| Quarterly revenue | $2M | 2025-12-31 | 0001635088-26-000011 |
| Quarterly diluted EPS | -0.38 | 2025-12-31 | 0001635088-26-000011 |
SEC EDGAR Frames batch generated 2026-07-16T23:27:27.083Z. Frames are calendar-aligned and may not cover every filer or fiscal period.
Dividends
Trailing 12 months
Not published
Latest payment
Not published
Yahoo Finance corporate actions. Window: 2025-07-17 through 2026-07-17.
Seasonality
| Month | Mean return | Positive | n |
|---|
Monthly close-to-close returns, trailing 15 years where Yahoo history is available.
Sector news
No matching sector headlines were returned in the 72-hour window.
Filings and machine access
Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract
Context paths
HealthcareNasdaqBMY · Tier 1 peerDHR · Tier 1 peerTMO · Tier 1 peerPFE · Tier 1 peer
Provenance
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames